Literature DB >> 7989521

Human menopausal gonadotrophin increases pregnancy rate in comparison with clomiphene citrate during replacement cycles of frozen/thawed pronucleate ova.

I Van der Auwera1, C Meuleman, P R Koninckx.   

Abstract

In a prospective randomized study, the effect of two ovulation induction regimens on implantation rate of frozen/thawed pronucleate ova was investigated. Patients received either human menopausal gonadotrophin (HMG) or clomiphene/HMG. Ovulation induction was done on an individual basis using ultrasound and plasma 17 beta-oestradiol concentrations. Ovulation was induced with human chorionic gonadotrophin (HCG) when the leading follicle reached a diameter of 18 mm. Pronucleate ova had been frozen using the slow-freezing method of Lassalle et al. (1985) (Fertil. Steril., 44, 645-651) and were thawed in synchrony with the age of the endometrium. Both groups of patients were comparable for age, indication for in-vitro fertilization, pre-ovulatory 17 beta-oestradiol concentration, number of large follicles and number and quality of embryos transferred. The only difference found was that HCG was administered 1 day earlier in the HMG group compared to the clomiphene/HMG group (P < 0.01). Using univariate analysis, the pregnancy rate was higher in patients stimulated with HMG alone compared to those stimulated with clomiphene/HMG (27 versus 15% respectively; P < 0.03), when HCG was administered later in the menstrual cycle (P < 0.01) and when more and better quality embryos were transferred (P < 0.01). Using multivariate regression analysis, the influence of the stimulation on pregnancy rate was even more pronounced (P < 0.01) when the day of HCG administration and the number and quality embryos transferred were taken into account. Therefore, we conclude that HMG alone increases pregnancy rate compared to clomiphene/HMG during replacement cycles of frozen/thawed pronucleate ova. These data suggest that HMG results in a better endometrium receptivity for embryos.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989521     DOI: 10.1093/oxfordjournals.humrep.a138748

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

Review 1.  Preparation of endometrium for frozen embryo replacement cycles: a systematic review and meta-analysis.

Authors:  Hakan Yarali; Mehtap Polat; Sezcan Mumusoglu; Irem Yarali; Gurkan Bozdag
Journal:  J Assist Reprod Genet       Date:  2016-08-22       Impact factor: 3.412

2.  Transfer of cryopreserved - thawed embryos in hCG induced natural or clomiphene citrate cycles yields similar live birth rates in normo-ovulatory women.

Authors:  Dimitra Kyrou; Human M Fatemi; Christophe Blockeel; Dominic Stoop; H Albuarki; Greta Verheyen; Paul Devroey
Journal:  J Assist Reprod Genet       Date:  2010-08-12       Impact factor: 3.412

Review 3.  Oral versus injectable ovulation induction agents for unexplained subfertility.

Authors:  N Athaullah; M Proctor; N P Johnson
Journal:  Cochrane Database Syst Rev       Date:  2002

4.  Mild stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist and its influence on serum estradiol level and pregnancy rate.

Authors:  Atsushi Yanaihara; Takeshi Yorimitsu; Hiroshi Motoyama; Motohiro Ohara; Toshihiro Kawamura
Journal:  Reprod Med Biol       Date:  2008-04-17

5.  Perinatal outcomes of neonates born from different endometrial preparation protocols after frozen embryo transfer: a retrospective cohort study.

Authors:  Cheng Li; Yi-Chen He; Jing-Jing Xu; Yu Wang; Han Liu; Chen-Chi Duan; Chao-Yi Shi; Lei Chen; Jie Wang; Jian-Zhong Sheng; He-Feng Huang; Yan-Ting Wu
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-29       Impact factor: 3.007

6.  Preparation of the Endometrium for Frozen Embryo Transfer: A Systematic Review.

Authors:  Sezcan Mumusoglu; Mehtap Polat; Irem Yarali Ozbek; Gurkan Bozdag; Evangelos G Papanikolaou; Sandro C Esteves; Peter Humaidan; Hakan Yarali
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-09       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.